Urology

Time to say goodbye to minocycline?
Drug and Therapeutics Bulletin May 2013, 51 (5) 49; DOI: 10.1136/dtb.2013.5.0176
DTB Select: 4 | April 2016
Drug and Therapeutics Bulletin Apr 2016, 54 (4) 38-41; DOI: 10.1136/dtb.2016.4.0392
Taking the hype out of hypertension
Drug and Therapeutics Bulletin Oct 2014, 52 (10) 109; DOI: 10.1136/dtb.2014.10.0280
Fosfomycin for UTIs
Drug and Therapeutics Bulletin Oct 2016, 54 (10) 114-117; DOI: 10.1136/dtb.2016.10.0429
HbA_1c targets in type 2 diabetes: guidelines and evidence
Drug and Therapeutics Bulletin Apr 2013, 51 (4) 42-45; DOI: 10.1136/dtb.2013.4.0172
Prevention of recurrent urinary tract infections in women
Drug and Therapeutics Bulletin Jun 2013, 51 (6) 69-74; DOI: 10.1136/dtb.2013.6.0187
▼Dapagliflozin (Forxiga) for type 2 diabetes?
Drug and Therapeutics Bulletin Sep 2013, 51 (9) 105-108; DOI: 10.1136/dtb.2013.9.0205
Paper to change practice: Magnesium sulphate for eclampsia
Drug and Therapeutics Bulletin Oct 1995, 33 (10) 80; DOI: 10.1136/dtb.1995.331080
Alcoholic neglect
Drug and Therapeutics Bulletin May 2010, 48 (5) 49; DOI: 10.1136/dtb.2010.03.0021
Tyrosine kinase inhibitors for metastatic renal cell carcinoma
Drug and Therapeutics Bulletin Nov 2011, 49 (11) 129-132; DOI: 10.1136/dtb.2011.02.0069

Main menu